Potential Impacts of Hydralazine as a Novel Antioxidant on Cardiovascular and Renal Disease—Beyond Vasodilation and Blood Pressure Lowering

Hydralazine is a traditional antihypertensive drug that was developed several decades ago. Its most well-known effect is blood pressure lowering by arterial vasodilation. While mainly used an adjunct treatment for clinical hypertension or chronic heart failure, this old drug has also shown potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ting-Ting, Chen, Jaw-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686999/
https://www.ncbi.nlm.nih.gov/pubmed/36421409
http://dx.doi.org/10.3390/antiox11112224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686999/
https://www.ncbi.nlm.nih.gov/pubmed/36421409
http://dx.doi.org/10.3390/antiox11112224

Ejemplares similares